An interventional study of Physical Activity and Health Program in Cancer, sponsored by University of Liege. Completed at 1 site in Belgium. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by University of Liege · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study evaluates a community-based physical activity programme designed to bridge the gap between hospital-based rehabilitation and independent physical activity close to home for cancer survivors. Over 12 weeks, changes in quality of life, fatigue, sleep quality, anxiety, depression and physical activity were assessed using validated questionnaires, alongside participants' motivation, expectations and satisfaction. Although no significant improvements were observed in the main health outcomes, participants reported high satisfaction and increased confidence in continuing physical activity independently. These findings highlight the potential of community-based programmes to support the transition towards long-term physical activity after cancer treatment.
Detailed Description
Study Design and Objectives
This was a prospective, single-arm interventional study without a control group, using a pre-test/post-test design. The study aimed to evaluate the effects of a 12-week adapted physical activity program in cancer survivors in remission. Participants were assessed before the intervention (T0) and at the end of the program (T3) to examine changes in the outcomes of interest.
Cancer and its treatments can negatively affect physical functioning, quality of life, fatigue, sleep, and psychological well-being. Although physical activity is recommended for cancer survivors, maintaining regular physical activity after completing cancer treatment and hospital-based rehabilitation can be challenging. Community-based adapted physical activity programs may help facilitate the transition from supervised hospital rehabilitation to independent physical activity.
The "Physical Activity and Health" program was developed to provide cancer survivors with access to adapted physical activity sessions close to their place of residence. The program aimed to promote regular physical activity, improve physical and psychological well-being, and encourage long-term autonomy in physical activity practice.
The objective of this study was to assess changes in physical activity levels, quality of life, fatigue, sleep quality, anxiety and depressive symptoms, participant satisfaction, and perceived autonomy in physical activity practice following participation in the program.
Study Population
Participation was voluntary and subject to predefined inclusion and exclusion criteria.
Inclusion criteria:
History of any type of cancer.
Exclusion criteria:
The study was approved by the University Hospital Ethics Committee of Liège (approval number: B7072020000105). All participants provided written informed consent before participating in the study.
Intervention
The intervention consisted of one 90-minute adapted physical activity session per week over 12 weeks. Sessions were supervised by a physiotherapist and/or a physical education specialist.
Each session included exercises targeting muscular endurance, posture, and cardiovascular fitness, followed by stretching exercises involving the major muscle groups. Equipment included body weight, exercise mats, Swiss balls, elastic bands, and light weights. Exercises were adapted to participants' physical condition and abilities.
Data Collection and Questionnaires
Participants completed self-administered questionnaires at baseline (T0), before the intervention, and at the end of the 12-week program (T3). Baseline questionnaires were completed at home and collected during the subsequent session. At T3, participants completed the same questionnaires, together with a program satisfaction questionnaire.
Sociodemographic data included sex, age, height, weight, marital status, education level, employment status, and perceived psychological and social support. Medical data included cancer type, treatments received, and history of recurrence.
Physical activity questionnaires assessed weekly activity duration, types of activities performed, and barriers to participation. Additional questionnaires collected information on sources of information about the program, communication preferences, motivation, and expectations.
4.1. Fatigue Assessment
Fatigue was assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue), Version 4. This 13-item questionnaire yields a total score ranging from 0 to 52, with higher scores indicating less fatigue. It was administered at T0 and T3.
4.2. Sleep Quality Assessment
Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI), which comprises 19 questions contributing to seven components. The total score ranges from 0 to 21, with scores above 5 suggesting poor sleep quality. Higher scores indicate poorer sleep quality. The questionnaire was administered at T0 and T3.
4.3. Anxiety and Depression Assessment
Anxiety and depressive symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS), a 14-item questionnaire comprising two subscales: anxiety and depression. Each subscale ranges from 0 to 21, with higher scores indicating more severe symptoms. The questionnaire was administered at T0 and T3.
4.4. Quality of Life Assessment
Health-related quality of life was assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), Version 3.0. This 30-item questionnaire assesses global health status, five functional domains, and several symptom domains. Scores range from 0 to 100. Higher scores indicate better functioning and global health status, whereas higher symptom scores indicate a greater symptom burden. The questionnaire was administered at T0 and T3.
4.5. Physical Activity, Motivation, and Satisfaction
Physical activity questionnaires assessed weekly activity duration, types of activities performed, and barriers to participation. A motivation and expectations questionnaire was completed at enrollment to identify factors potentially influencing participation and adherence. A satisfaction questionnaire was administered at the end of the program to assess participants' perceptions of the intervention.
Statistical Analysis and Data Management
Data were entered into an Excel spreadsheet, and each participant was assigned a unique identification number. Data used for statistical analyses were pseudonymized to protect participants' confidentiality while allowing assessments from the same participant at T0 and T3 to be linked.
Statistical analyses were performed using R Commander. Categorical variables were summarized as percentages. Quantitative variables were described using means and standard deviations or medians and interquartile ranges, depending on their distribution.
Changes between T0 and T3 were assessed using paired Student's t-tests for normally distributed quantitative variables, Wilcoxon signed-rank tests for non-normally distributed quantitative variables, and McNemar's tests for paired binary variables.
The study was approved by the University Hospital Ethics Committee of Liège (approval number: B7072020000105). Participation was voluntary, and all participants provided written informed consent before enrollment. Data were pseudonymized to protect participants' confidentiality during data processing and analysis.
10,832 studies on the registry are indexed under Neoplasms; 2,324 are open to participants now.
This study's enrollment of 30 is below the median of 60 across 7,712 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →University of Liege is the lead sponsor of 252 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adults aged 18 years or older.
History of any type of cancer.
Completion of chemotherapy and/or radiotherapy.
Medical certificate confirming fitness to participate in physical activity.
Written provided by the participant.
Exclusion Criteria
Ongoing chemotherapy and/or radiotherapy.
Any medical to physical activity.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants take part in a 12-week adapted physical activity program consisting of one supervised 1.5-hour session per week, led by a physiotherapist and/or a physical education specialist. The sessions include muscular endurance, postural exercises, cardiovascular conditioning, and stretching.
Behavioral: Physical Activity and Health Program
Participants take part in a 12-week adapted physical activity program designed for cancer survivors who have completed chemotherapy and/or radiotherapy. The program consists of one supervised 1.5-hour session per week. Sessions are supervised by a physiotherapist and/or a physical education specialist and include muscular endurance exercises, postural exercises, cardiovascular conditioning, and stretching of major muscle groups. Exercises are adapted to participants' abilities and use body weight, exercise mats, Swiss balls, elastic bands, and light weights.
Quality of Life (EORTC QLQ C-30)
Time frame: From enrollment to the end of treatment at 12 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Feb 2023 to primary completion in Feb 2025, 24 months.
Of 1,988 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's 24 months is below that.
Counting every sponsor, half of 2,063 studies reached it within 29 months; a quarter within 13 and three quarters within 52.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.